KOPRAN NSI Week ended 07 Aug 2026

Weekly Investor Report

Kopran Limited · Healthcare · Drug Manufacturers - General

Open interactive chart View report data
Latest close 181.2 INR
-5.1% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 13.9% above the Trend Line and sits at 66.3% of its 52-week range. The latest completed week returned -5.1%, after a -7.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 43/100. Near-term considerations: volume confirmation is below normal.

Setup score 48 out of 100
Latest Close 181.2 INR 7 Aug 2026
1W Return -5.1% latest completed week
4W Return -7.9% short-term follow-through
12W Return 15.9% quarterly tape
Trend Breadth 23.1% 12 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • The trend backdrop is active with a 12-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 43.34% based on similar historical setup states.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -5.1% Latest completed week; four-week move -7.9%. Indicator stack 54/56 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.34% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 43/100 13 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 13.9% above the Trend Line and sits at 66.3% of its 52-week range. The latest completed week returned -5.1%, after a -7.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9612-week average 0.79

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.96Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.9% over four weeks, 15.9% over 12 weeks, and 17.4% over one year. The current trend has remained active for 12 consecutive weeks.

Performance by holding period

1W-5.1%
4W-7.9%
12W15.9%
26W29.4%
52W17.4%
Active trend streak12 weeks
Active weeks in one year12
Trend breadth23.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.58Latest activity-pressure read.
Pressure change-54.9%Four-week change in activity pressure.
Leadership15.37Latest relative-leadership reading.
RS change-47.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength83/100Blend of value, momentum, and quality. Underlying universe rank 18; rank 1 is best.
Value76/100Relative valuation strength. Underlying universe rank 25; rank 1 is best.
Quality34/100Profitability and accounting quality. Underlying universe rank 67; rank 1 is best.
Momentum79/100Medium-term price momentum. Underlying universe rank 22; rank 1 is best.
Growth16/100Revenue and earnings growth. Underlying universe rank 85; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework55/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
34.0x
Price divided by trailing earnings.
Price / sales
1.3x
Market value relative to trailing revenue.
EV / EBITDA
16.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
35.6%
Gross profit retained from each unit of revenue.
Operating margin
8.9%
Operating profit retained from revenue.
Free-cash-flow margin
-0.1%
Free cash flow generated from revenue.
Return on invested capital
6.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.3%
Latest one-year revenue growth.
EPS growth
-33.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.7%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
1.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment43/100

Weighted news tone is neutral across 13 relevant articles.

1 positive · 10 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.3%Distance below the 52-week high.
13-week volatility8.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+31.2%Week of 10 Apr.
Worst week-8.3%Week of 5 Jun.
Latest week-5.1%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses8
Sharp losses6
Recent vol8.4%13-week weekly-return volatility.
Base vol7.7%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew6.5% / -4.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape51/100

Trend, activity pressure, participation, and risk combine to a 51/100 tape read.

 Indicator analysis91/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.96; No reversal markers Next-Week ExpectancyNegative 43.34%

Next-week expectancy is negative with a 43.34% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors67/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 42; Small Cap Core rank 28 SVQF55/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 713.0 of 1576 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment43/100

Weighted news tone is neutral across 13 relevant articles.

Kopran net profit falls 10% to ₹670.09 lakh in Q1FY26 as margins compress Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026181.2 INR-5.1%159.2 INR204.5 INR0.5815.37723.9KOn
31 Jul 2026191.0 INR-3.9%158.1 INR204.4 INR1.0022.94432.6KOn
24 Jul 2026198.7 INR-2.4%156.8 INR204.2 INR1.2031.80562.7KOn
17 Jul 2026203.6 INR3.5%155.1 INR204.1 INR1.2732.51943.5KOn
10 Jul 2026196.8 INR1.8%152.7 INR204.0 INR1.2829.29526.6KOn
3 Jul 2026193.3 INR1.9%150.5 INR203.8 INR1.2027.10146.6KOn
26 Jun 2026189.6 INR-2.3%148.5 INR203.7 INR1.2026.160On
19 Jun 2026194.0 INR6.8%146.7 INR203.6 INR1.4229.62170.4KOn
12 Jun 2026181.6 INR-3.9%144.5 INR203.4 INR1.5223.6559.7KOn
5 Jun 2026189.1 INR-8.3%143.2 INR203.4 INR1.4930.08175.0KOn
29 May 2026206.3 INR26.4%142.2 INR203.3 INR1.5141.0321.4MOn
22 May 2026163.2 INR4.4%140.8 INR203.1 INR1.3611.279.0MOn
15 May 2026156.3 INR-3.5%141.1 INR202.9 INR1.286.78840.4KOff
8 May 2026162.0 INR-1.6%141.4 INR202.8 INR1.418.051.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context